Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 7.22 USD -3.22% Market Closed
Market Cap: 500m USD

Intrinsic Value

The intrinsic value of one BCYC stock under the Base Case scenario is 8.22 USD. Compared to the current market price of 7.22 USD, Bicycle Therapeutics PLC is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BCYC Intrinsic Value
8.22 USD
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bicycle Therapeutics PLC

What is Valuation History?
Compare BCYC to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BCYC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bicycle Therapeutics PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bicycle Therapeutics PLC

Current Assets 856.1m
Cash & Short-Term Investments 793m
Receivables 46.4m
Other Current Assets 16.7m
Non-Current Assets 27.8m
PP&E 15.4m
Other Non-Current Assets 12.4m
Efficiency

Free Cash Flow Analysis
Bicycle Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bicycle Therapeutics PLC

Revenue
25.7m USD
Operating Expenses
-269.6m USD
Operating Income
-243.8m USD
Other Expenses
40.6m USD
Net Income
-203.2m USD
Fundamental Scores

BCYC Profitability Score
Profitability Due Diligence

Bicycle Therapeutics PLC's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
13/100
Profitability
Score

Bicycle Therapeutics PLC's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

BCYC Solvency Score
Solvency Due Diligence

Bicycle Therapeutics PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
57/100
Solvency
Score

Bicycle Therapeutics PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BCYC Price Targets Summary
Bicycle Therapeutics PLC

Wall Street analysts forecast BCYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCYC is 26.44 USD with a low forecast of 13.13 USD and a high forecast of 50.4 USD.

Lowest
Price Target
13.13 USD
82% Upside
Average
Price Target
26.44 USD
266% Upside
Highest
Price Target
50.4 USD
598% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Bicycle Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for BCYC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BCYC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BCYC stock?

The intrinsic value of one BCYC stock under the Base Case scenario is 8.22 USD.

Is BCYC stock undervalued or overvalued?

Compared to the current market price of 7.22 USD, Bicycle Therapeutics PLC is Undervalued by 12%.

Back to Top